FRACCARO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.008
EU - Europa 647
AS - Asia 267
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.006
IT - Italia 212
CN - Cina 206
FI - Finlandia 117
SE - Svezia 104
GB - Regno Unito 85
DE - Germania 61
UA - Ucraina 41
IN - India 29
VN - Vietnam 27
IE - Irlanda 8
FR - Francia 5
NL - Olanda 3
RU - Federazione Russa 3
AT - Austria 2
CA - Canada 2
EU - Europa 2
GR - Grecia 2
TR - Turchia 2
CZ - Repubblica Ceca 1
HK - Hong Kong 1
JP - Giappone 1
LU - Lussemburgo 1
PL - Polonia 1
RO - Romania 1
SG - Singapore 1
Totale 4.924
Salva come PNG Salva come JPEG
Città #
Fairfield 642
Chandler 479
Woodbridge 375
Ashburn 309
Houston 301
Cambridge 238
Seattle 213
Ann Arbor 200
Wilmington 196
Jacksonville 171
Princeton 97
San Diego 84
Medford 79
Des Moines 71
Helsinki 69
Beijing 68
Padova 51
Roxbury 49
Nanjing 42
Dong Ket 27
Boardman 23
London 23
Milan 22
Ogden 22
New York 18
Hebei 11
Shenyang 11
Nanchang 10
Norwalk 10
Rome 9
Dublin 8
Falls Church 7
Palermo 7
Redwood City 7
Cagliari 6
Dearborn 6
Nashville 6
Schio 6
Changsha 5
Los Angeles 5
Jiaxing 4
Kunming 4
Villorba 4
Westfield 4
Boydton 3
Carol Stream 3
Casier 3
Forlì 3
Genoa 3
Mortara 3
Ningbo 3
Ospedaletto Euganeo 3
Salerno 3
Santa Clara 3
Bollate 2
Borehamwood 2
Borås 2
Chiswick 2
Civitavecchia 2
Costa Mesa 2
Easton 2
Foggia 2
Forno 2
Guangzhou 2
Hangzhou 2
Hanover 2
Hefei 2
Iseo 2
Jinan 2
Kharkiv 2
Kilburn 2
Marostica 2
Moscow 2
Munich 2
Mussolente 2
Naples 2
Phoenix 2
Portland 2
Redmond 2
Rockville 2
San Severino Marche 2
Taizhou 2
Temecula 2
Tianjin 2
Trieste 2
Vienna 2
Wenzhou 2
Wuhan 2
Yellow Springs 2
Acton 1
Amsterdam 1
Augusta 1
Bucharest 1
Changchun 1
Chaoyang 1
Chicago 1
Edinburgh 1
Esslingen am Neckar 1
Falkenstein 1
Frisco 1
Totale 4.110
Salva come PNG Salva come JPEG
Nome #
Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. 105
Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation 101
Development and validation of a distal embolization risk score during primary angioplasty in ST-elevation myocardial infarction 100
Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. 99
Another passenger for the TAVR speeding train 98
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 97
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 96
Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction 94
Predictors and time-related impact of distal embolization during primary angioplasty 91
Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction 90
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 89
Impact of myocardial staining on In-hospital outcome after primary percutaneous coronary intervention in the Padua Registry on ST-elevation myocardial infarction 88
Relation of aortic valve weight to severity of aortic stenosis. 83
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed by Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy 79
Ventricular assist devices. 78
Transcatheter aortic valve implantation at institutions without cardiovascular surgery departments: Many questions still linger before a paradigm shift 77
Transcatheter aortic valve implantation and bleeding: focus on Valve Academic Research Consortium-2 classification. 76
Transcatheter aortic valve implantation 76
Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. 74
Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation 74
Transcatheter aortic valve implantation and bleeding: Focus on Valve Academic Research Consortium-2 classification. 73
Transcatheter aortic valve implantation in patients younger than 75 years: Guidelines-based patients selection and clinical outcome 72
Using wearable devices to monitor physical activity in patients undergoing aortic valve replacement: Protocol for a prospective observational study 71
Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications 71
Age-related outcome of percutaneous mitral balloon valvuloplasty 69
Intermediate clinical and hemodynamic outcomes after transcatheter aortic valve implantation presented at the fifty-first annual meeting of the society of thoracic surgeons, San Diego, CA, Jan 24-28, 2015 69
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis 69
Transfemoral aortic valve implantation of an Edwards Sapien XT valve in a patient with a mechanical mitral prosthesis. 67
Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after tavr-in-tavr 67
Renal insufficiency and left main coronary artery disease: reconsidering coronary intervention and bypass surgery 66
The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 66
Conduction Abnormalities after Transcatheter Aortic Valve Implantation for Calcitic Aortic Valve Disease 65
Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction 65
Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19 63
Percutaneous treatment of spontaneous coronary artery dissection 62
Initial Q Wave at Presentation of Acute Myocardial Infarction is Better Than Time to Treatment in Predicting Myocardial and Microvascular Damage in Patients with Anterior Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 62
Echocardiographic follow-up after transcatheter aortic valve replacement 62
Long-term outcomes and prosthesis performance after transcatheter aortic valve replacement: Results of self-expandable and balloon-expandable transcatheter heart valves 61
Totally percutaneous valve replacement for severe aortic regurgitation in a degenerating bioprosthesis 61
Time-dependent Impact of Distal Embolization on Myocardial and Microvascular Damage During Primary-Percutaneous Coronary Intervention: a Prospective Magnetic Resonance Study 59
Predictors and time-related impact of distal embolization during primary angioplasty. 59
Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents. 57
Left ventricular outflow tract rupture during transcatheter aortic valve implantation: anatomic evidence of the vulnerable area 56
Valve replacement for severe aortic stenosis with low transvalvular gradient and left ventricular ejection fraction exceeding 0.50. 55
Impact of Aortic Valve Replacement on Survival of Patients With Severe Aortic Stenosis With Low Transvalvular Gradient and Preserved Left Ventricular Ejection Fraction 54
Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. 54
Incidence and feasibility of coronary access after transcatheter aortic valve replacement 54
Eligibility to Percutaneous Aortic Valve Replacement in Patients at High-Risk for Surgery. Insight from PUREVALVE Registry Selection Phase 51
Assessing the Impact of Distal Embolization on Myocardial and Microvascular Damage during primary-Percutaneous Coronary Intervention: A Prospective Magnetic Resonance Study 50
Impact Of Multivessel Coronary Disease On Late Clinical Outcome In Patients With St-elevation Myocardial Infarction Is Not Due To The Extent Of Myocardial And Microvascular Injury Observed Early After Primary Angioplasty 49
Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study 49
Predictors of distal embolization during direct angioplasty for acute myocardial infarction 48
Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE neo valve 48
Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis 47
Myocardial blush grade predicts myocardial and microvascular damage in ST-elevation myocardial infarction patients who underwent direct angioplasty 46
Acute coronary syndrome with clear coronary artery: the case for concealed coronary hematoma. 46
[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation] 46
Outcome of Coronary Ostial Stenting to Prevent Coronary Obstruction during Transcatheter Aortic Valve Replacement 46
Time-related impact of distal embolization on myocardial reperfusion after direct angioplasty 44
Impact of High-Thrombus Burden Lesion on Distal Embolization and Myocardial Damage During Primary-Percutaneous Coronary Intervention: a Magnetic Resonance Study 44
Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation. 44
Incidence and Management of Vascular Complications in Percutaneous Aortic Valve Replacement 43
Left Anterior Descending Artery Myocardial Bridging: A Clinical Approach 42
Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses 42
Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry 41
Twilight-specific light cues 40
Percutaneous mitral balloon valvuloplasty after surgical commissurotomy: a comparative study 39
Sleep quality in patients undergoing transcatheter aortic valve implantation (Tavi) 39
Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study 39
Improvement of symptoms and coronary perfusion gradient with mechanical left ventricular unloading in flow-limiting complex spontaneous coronary artery dissection, without revascularization 38
Eligibility to Percutaneous Aortic Valve Replacement In Patients at High-Risk for Surgery. Insight from PUREVALVE Registry Selection Phase 37
[The CHOICE study]. 37
The anatomy is the plastic image of function: the role of the ventricle-aortic angle in TAVR 37
Coronary sinus reducer implantation in the middle cardiac vein for the treatment of refractory angina 36
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement 36
Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results 35
[High-risk ST-elevation acute coronary syndrome in a patient with multivessel coronary artery disease complicated by refractory cardiogenic shock undergoing complex percutaneous coronary revascularization: role and timing of mechanical circulatory support devices] 34
High-risk percutaneous coronary intervention using hemodynamic support device eight years after transcatheter aortic valve implantation 31
Incidence, Causes, and Outcomes Associated With Urgent Implantation of a Supplementary Valve During Transcatheter Aortic Valve Replacement 29
Predictors of systemic embolism after successful balloon mitral valvuloplasty 28
Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3 27
Transcatheter aortic valve-in-valve implantation for the treatment of a failed surgical bioprosthesis of small size 26
Percutaneous closure of a very wide interatrial septal defect: clinical case and literature review 25
Prognosis of Mild and Moderate Aortic Stenosis 23
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease 17
Procedura percutanea combinata di riparazione dell’insufficienza mitralica con tecnica “edge-to-edge” e di chiusura dell’auricola sinistra 17
Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction 17
Position paper of the Italian Society of Interventional Cardiology (SICI-GISE): Management of patent foramen ovale in patients with cerebral or systemic thromboembolism - 2020 16
Prevalence and Prognostic Impact of Carotid Artery Disease in Patients Undergoing TAVI 16
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type 2
Totale 5.021
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.562
article - articoli 20.252
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019264 0 0 0 0 0 0 0 0 0 0 134 130
2019/2020796 122 21 11 47 74 73 73 108 72 77 85 33
2020/2021785 19 31 94 59 37 70 59 84 106 57 83 86
2021/20221.171 28 130 114 78 61 120 37 120 95 41 84 263
2022/2023999 194 102 36 117 131 131 8 46 96 16 50 72
2023/2024410 9 86 49 32 50 55 36 29 38 23 3 0
Totale 5.021